Galmed Pharmaceuticals Ltd expected to post a loss of $3.12 a share - Earnings Preview
24/08/2026 13:33
Galmed Pharmaceuticals Ltd <GLMD.OQ> expected to post a loss of $3.12 a share - Earnings Preview
Galmed Pharmaceuticals Ltd GLMD.OQ GLMD.O is expected to report results on August 26 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Galmed Pharmaceuticals Ltd is for a loss of $3.12 per share.
The one available analyst rating on the shares is "hold".
The mean earnings estimate of analysts was unchanged in the last three months.
This summary was machine generated August 24 at 12:33 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)